X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SHASUN PHARMA TTK HEALTHCARE/
SHASUN PHARMA
 
P/E (TTM) x 22.9 123.9 18.5% View Chart
P/BV x 7.7 8.5 90.4% View Chart
Dividend Yield % 0.4 0.2 161.5%  

Financials

 TTK HEALTHCARE   SHASUN PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SHASUN PHARMA
Mar-14
TTK HEALTHCARE/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs66394 704.2%   
Low Rs39946 875.0%   
Sales per share (Unadj.) Rs535.6214.2 250.1%  
Earnings per share (Unadj.) Rs15.95.3 298.8%  
Cash flow per share (Unadj.) Rs20.015.8 126.6%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.81.4 52.6%  
Book value per share (Unadj.) Rs137.653.3 258.0%  
Shares outstanding (eoy) m7.7756.62 13.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.3 303.9%   
Avg P/E ratio x33.313.1 254.3%  
P/CF ratio (eoy) x26.54.4 600.3%  
Price / Book Value ratio x3.91.3 294.6%  
Dividend payout %25.118.7 133.9%   
Avg Mkt Cap Rs m4,1273,958 104.3%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6072,164 28.0%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16212,127 34.3%  
Other income Rs m61229 26.7%   
Total revenues Rs m4,22312,356 34.2%   
Gross profit Rs m1971,009 19.5%  
Depreciation Rs m32594 5.3%   
Interest Rs m30415 7.2%   
Profit before tax Rs m197230 85.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-73 -100.1%   
Profit after tax Rs m124302 41.0%  
Gross profit margin %4.78.3 56.9%  
Effective tax rate %37.0-31.7 -116.9%   
Net profit margin %3.02.5 119.5%  
BALANCE SHEET DATA
Current assets Rs m1,6296,884 23.7%   
Current liabilities Rs m1,0588,456 12.5%   
Net working cap to sales %13.7-13.0 -105.8%  
Current ratio x1.50.8 189.1%  
Inventory Days Days3062 48.3%  
Debtors Days Days34108 31.2%  
Net fixed assets Rs m5564,970 11.2%   
Share capital Rs m78113 68.6%   
"Free" reserves Rs m8782,875 30.6%   
Net worth Rs m1,0693,020 35.4%   
Long term debt Rs m1591,817 8.7%   
Total assets Rs m2,39913,347 18.0%  
Interest coverage x7.61.6 487.9%   
Debt to equity ratio x0.10.6 24.7%  
Sales to assets ratio x1.70.9 190.9%   
Return on assets %6.45.4 119.3%  
Return on equity %11.610.0 115.8%  
Return on capital %18.513.3 138.5%  
Exports to sales %0.846.4 1.7%   
Imports to sales %1.414.2 9.8%   
Exports (fob) Rs m335,622 0.6%   
Imports (cif) Rs m581,728 3.4%   
Fx inflow Rs m335,843 0.6%   
Fx outflow Rs m632,173 2.9%   
Net fx Rs m-303,669 -0.8%   
CASH FLOW
From Operations Rs m127398 31.8%  
From Investments Rs m-146-1,635 8.9%  
From Financial Activity Rs m221,309 1.7%  
Net Cashflow Rs m371 3.5%  

Share Holding

Indian Promoters % 65.4 39.2 166.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 3.6 102.8%  
FIIs % 5.2 17.6 29.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 39.6 65.2%  
Shareholders   12,723 20,750 61.3%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

Revenge of the Ratings Agencies(Vivek Kaul's Diary)

Sep 7, 2018

Do you remember when ratings agencies ruled financial markets? Nick explains why he thinks it's time to prepare yourselves for a comeback of the ratings agencies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS